Inspire Medical Systems Inc (INSP)
Inspire Medical Systems, Inc. is a healthcare technology company focused on developing and commercializing minimally invasive treatment options for patients with obstructive sleep apnea (OSA) in the United States and other markets. Its principal product is the Inspire system, a neurostimulation therapy designed for adults with moderate to severe OSA. The company also works on a closed-loop solution that monitors breathing and delivers mild hypoglossal nerve stimulation to help keep the airway open. Incorporated in 2007, Inspire Medical Systems is headquartered in Golden Valley, Minnesota, and its common stock is listed on the New York Stock Exchange under the symbol INSP.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-INSP
|
$87.60
|
14.1% Upside
|
Fair
|
$61.07
|
-20.5% Downside
|
Overvalued
|
Great
|
0.0%
|
November 9, 2026
|
16.4x
|
2.7x
|
2.5x
|
2.22 B
|
1.816 B
|
1.4%
|
80.5%
|
14.2
|
86.7%
|
